UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Rapid Point-of-Care Test for the Serodiagnosis of Hepatitis Delta Virus Infection

Viruses, 2021-11, Vol.13 (12), p.2371

2021

Volltextzugriff (PDF)

Increasing prevalence of HDV/HBV infection over 15 years in France

Journal of clinical virology, 2014-02, Vol.59 (2), p.126-128

2014

Volltextzugriff (PDF)

Hepatitis B, C, and delta in the general population in Mayotte: hepatitis B as a major public health concern

BMC infectious diseases, 2022-08, Vol.22 (1), p.1-716, Article 716

2022

Volltextzugriff (PDF)

The Prevalence and Molecular Epidemiology of Hepatitis Delta Virus in Nigeria: The Results of a Nationwide Study

Viruses, 2024-07, Vol.16 (8), p.1236

2024

Volltextzugriff (PDF)

Variable In Vivo Hepatitis D Virus (HDV) RNA Editing Rates According to the HDV Genotype

Viruses, 2021-08, Vol.13 (8), p.1572

2021

Volltextzugriff (PDF)

Comprehensive Analysis of Hepatitis Delta Virus Assembly Determinants According to Genotypes: Lessons From a Study of 526 Hepatitis Delta Virus Clinical Strains

Frontiers in microbiology, 2021-11, Vol.12, p.751531-751531

2021

Volltextzugriff (PDF)

Efficacy of peginterferon alpha‐2b in chronic hepatitis delta: Relevance of quantitative RT‐PCR for follow‐up

Hepatology (Baltimore, Md.), 2006-09, Vol.44 (3), p.728-735

2006

Volltextzugriff (PDF)

Eighth major clade for hepatitis delta virus

Emerging infectious diseases, 2006-09, Vol.12 (9), p.1447-1450

2006

Volltextzugriff (PDF)

Clinical and virological features of chronic hepatitis B in the French national surveillance program, 2008–2012: A cross-sectional study

JHEP reports, 2022-12, Vol.4 (12), p.100593-100593, Article 100593

2022

Volltextzugriff (PDF)

Epidemiological data for hepatitis D in Africa

The Lancet global health, 2018-01, Vol.6 (1), p.e33-e33

2018

Volltextzugriff (PDF)

Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtide

JHEP reports, 2024-08, Vol.6 (8), p.101070, Article 101070

2024

Volltextzugriff (PDF)

Molecular Phylogenetic Analyses Indicate a Wide and Ancient Radiation of African Hepatitis Delta Virus, Suggesting a Deltavirus Genus of at Least Seven Major Clades

Journal of Virology, 2004-03, Vol.78 (5), p.2537-2544

2004

Volltextzugriff (PDF)

550 SAFETY AND EFFICACY OF REP 2139-MG IN ASSOCIATION WITH TDF IN PATIENTS WITH CHRONIC HEPATITIS DELTA AND DECOMPENSATED CIRRHOSIS

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-1252-S-1252

2023

Volltextzugriff (PDF)

Quantification of Hepatitis Delta Virus RNA in Serum by Consensus Real-Time PCR Indicates Different Patterns of Virological Response to Interferon Therapy in Chronically Infected Patients

Journal of Clinical Microbiology, 2005-05, Vol.43 (5), p.2363-2369

2005

Volltextzugriff (PDF)

Inhibition of Hepatitis B Virus Replication by the Interferon-Inducible MxA Protein

Journal of Virology, 2001-03, Vol.75 (6), p.2684-2691

2001

Volltextzugriff (PDF)

First international external quality assessment for hepatitis delta virus RNA quantification in plasma

Hepatology (Baltimore, Md.), 2016-11, Vol.64 (5), p.1483-1494

2016

Volltextzugriff (PDF)

A novel score to select patients for treatment in chronic hepatitis B: Results from a large Ethiopian cohort

Journal of hepatology, 2019-10, Vol.71 (4), p.840-841

2019

Volltextzugriff (PDF)

A new generic real-time PCR kit for hepatitis delta RNA viral load quantification

Journal of Virus Eradication, 2016-05, Vol.2, p.13-14

2016

Volltextzugriff (PDF)

Hepatitis D virus infection markedly increases the risk of hepatocellular carcinoma in patients with viral B cirrhosis

Clinical gastroenterology and hepatology, 2024-10

2024

Volltextzugriff (PDF)

Genetic diversity and worldwide distribution of the deltavirus genus: A study of 2,152 clinical strains

Hepatology (Baltimore, Md.), 2017-12, Vol.66 (6), p.1826-1841

2017

Volltextzugriff (PDF)

Safety and efficacy of REP 2139-Mg in association with TDF in chronic hepatitis delta patients with decompensated cirrhosis

Journal of hepatology, 2023-06, Vol.78, p.S1160

2023

Volltextzugriff (PDF)

SAT-183 - Safety and efficacy of REP 2139-Mg in association with TDF in chronic hepatitis delta patients with decompensated cirrhosis

Journal of hepatology, 2023-06, Vol.78, p.S1160-S1160

2023

Volltextzugriff (PDF)

Hepatitis delta virus reflex testing in patients with hepatitis B improves the HDV screening cascade: 10 years of real-world experience from Avicenne University Hospital, France

Journal of hepatology, 2022-07, Vol.77, p.S271

2022

Volltextzugriff (PDF)

Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta

Journal of hepatology, 2020-11, Vol.73 (5), p.1046-1062

2020

Volltextzugriff (PDF)

Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial

The lancet. Gastroenterology & hepatology, 2017-12, Vol.2 (12), p.877-889

2017

Volltextzugriff (PDF)

1 – 25 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(90)

Publikationsform

Artikel
(99)
magazinearticle
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A Rapid Point-of-Care Test for the Serodiagnosis of Hepatitis Delta Virus Infection

Increasing prevalence of HDV/HBV infection over 15 years in France

Hepatitis B, C, and delta in the general population in Mayotte: hepatitis B as a major public health concern

The Prevalence and Molecular Epidemiology of Hepatitis Delta Virus in Nigeria: The Results of a Nationwide Study

Variable In Vivo Hepatitis D Virus (HDV) RNA Editing Rates According to the HDV Genotype

Comprehensive Analysis of Hepatitis Delta Virus Assembly Determinants According to Genotypes: Lessons From a Study of 526 Hepatitis Delta Virus Clinical Strains

Efficacy of peginterferon alpha‐2b in chronic hepatitis delta: Relevance of quantitative RT‐PCR for follow‐up

Eighth major clade for hepatitis delta virus

Clinical and virological features of chronic hepatitis B in the French national surveillance program, 2008–2012: A cross-sectional study

Epidemiological data for hepatitis D in Africa

Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtide

Molecular Phylogenetic Analyses Indicate a Wide and Ancient Radiation of African Hepatitis Delta Virus, Suggesting a Deltavirus Genus of at Least Seven Major Clades

550 SAFETY AND EFFICACY OF REP 2139-MG IN ASSOCIATION WITH TDF IN PATIENTS WITH CHRONIC HEPATITIS DELTA AND DECOMPENSATED CIRRHOSIS

Quantification of Hepatitis Delta Virus RNA in Serum by Consensus Real-Time PCR Indicates Different Patterns of Virological Response to Interferon Therapy in Chronically Infected Patients

Inhibition of Hepatitis B Virus Replication by the Interferon-Inducible MxA Protein

First international external quality assessment for hepatitis delta virus RNA quantification in plasma

A novel score to select patients for treatment in chronic hepatitis B: Results from a large Ethiopian cohort

A new generic real-time PCR kit for hepatitis delta RNA viral load quantification

Hepatitis D virus infection markedly increases the risk of hepatocellular carcinoma in patients with viral B cirrhosis

Genetic diversity and worldwide distribution of the deltavirus genus: A study of 2,152 clinical strains

Safety and efficacy of REP 2139-Mg in association with TDF in chronic hepatitis delta patients with decompensated cirrhosis

SAT-183 - Safety and efficacy of REP 2139-Mg in association with TDF in chronic hepatitis delta patients with decompensated cirrhosis

Hepatitis delta virus reflex testing in patients with hepatitis B improves the HDV screening cascade: 10 years of real-world experience from Avicenne University Hospital, France

Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta

Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial

Suchergebnisse filtern